Cargando…

Enhancing the Response Rate to Recombinant Uricases in Patients with Gout

Refractory, or uncontrolled, gout is a chronic, progressive, inflammatory arthropathy resulting from continued urate deposition after failed attempts to lower serum uric acid below the therapeutic threshold with oral urate-lowering therapies such as allopurinol and febuxostat. Recombinant uricase is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlesinger, Naomi, Padnick-Silver, Lissa, LaMoreaux, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Leading Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938732/ https://www.ncbi.nlm.nih.gov/pubmed/35316517 http://dx.doi.org/10.1007/s40259-022-00517-x

Ejemplares similares

Effect of Leflunomide on Pegloticase Response Rate in Patients with Uncontrolled Gout: A Retrospective Study
por: Masri, Karim Richard, et al.
Publicado: (2022)

Community Practice Experiences with a Variety of Immunomodulatory Agents Co-Administered with Pegloticase for the Treatment of Uncontrolled Gout
por: Broadwell, Aaron, et al.
Publicado: (2022)

Comparison Between Early-Onset and Common Gout: A Systematic Literature Review
por: Amatucci, Anthony J., et al.
Publicado: (2023)

Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
por: Francis-Sedlak, Megan, et al.
Publicado: (2020)

A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase: 12‐Month Findings
por: Botson, John K., et al.
Publicado: (2023)

Retreatment with Pegloticase after a Gap in Therapy in Patients with Gout: A Report of Four Cases
por: Morton, Allan H., et al.
Publicado: (2018)

Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study
por: Albert, John A., et al.
Publicado: (2020)

Systemic Urate Deposition: An Unrecognized Complication of Gout?
por: Khanna, Puja, et al.
Publicado: (2020)

Infusion-Related Reactions With Pegloticase, a Recombinant Uricase for the Treatment of Chronic Gout Refractory to Conventional Therapy
por: Baraf, Herbert S. B., et al.
Publicado: (2014)

Comparison of Rates of Lower Extremity Amputation in Patients With and Without Gout in the US Department of Veterans Affairs Health System
por: Mikuls, Ted R., et al.
Publicado: (2022)

Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout
por: Tan, Philip K., et al.
Publicado: (2016)

Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial
por: Botson, John K., et al.
Publicado: (2022)

Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
por: Tavares-Da-Silva, Fernanda, et al.
Publicado: (2020)

A Randomized, Placebo‐Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings
por: Botson, John K., et al.
Publicado: (2022)

Rapidly separating dissolving microneedles with sustained-release colchicine and stabilized uricase for simplified long-term gout management
por: Yang, Yao, et al.
Publicado: (2023)

Impact of Large Aggregated Uricases and PEG Diol on Accelerated Blood Clearance of PEGylated Canine Uricase
por: Zhang, Chun, et al.
Publicado: (2012)

A Retrospective Cohort Study of the Effect of Gout on Mortality Among Patients with a History of Kidney Transplantation
por: Li, Justin W., et al.
Publicado: (2020)

Gout. Imaging of gout: findings and utility
por: Perez-Ruiz, Fernando, et al.
Publicado: (2009)

PEAK EXPIRATORY FLOW RATE IN A SAMPLE OF NORMAL SAUDI MALES AT RIYADH, SAUDI ARABIA
por: Al-Taweel, Ahmed A., et al.
Publicado: (1999)

Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy
por: Abreu, Maria T, et al.
Publicado: (2022)

Enhancing Mood, Cognition, and Quality of Life in Pediatric Multiple Sclerosis
por: Fernandez-Carbonell, Cristina, et al.
Publicado: (2021)

Use of Pre-Infusion Serum Uric Acid Levels as a Biomarker for Infusion Reaction Risk in Patients on Pegloticase
por: Keenan, Robert T., et al.
Publicado: (2019)

An appropriate response to SARS
por: The Lancet Infectious Diseases
Publicado: (2003)

Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities
por: Kugener, Veronique F., et al.
Publicado: (2021)

SAT-424 Assessing Content Validity of the Graves’ Ophthalmopathy Quality of Life Questionnaire (GO-QOL) in the United States
por: Stan, Marius N, et al.
Publicado: (2020)

Are the Editors faced with e-problems performing their duties and responsibilities satisfactorily?
por: Ali Jawaid, Shaukat, et al.
Publicado: (2013)

Call for better response evaluation after neoadjuvant therapy in pancreatic cancer
por: Zaharia, Claudia, et al.
Publicado: (2023)

Untapping the Health Enhancing Potential of Vigorous Intermittent Lifestyle Physical Activity (VILPA): Rationale, Scoping Review, and a 4-Pillar Research Framework
por: Stamatakis, Emmanuel, et al.
Publicado: (2020)

Genetic Influences on Response to Mood Stabilizers in Bipolar Disorder: Current Status of Knowledge
por: Rybakowski, Janusz K.
Publicado: (2013)

Does food marketing need to make us fat? A review and solutions
por: Chandon, Pierre, et al.
Publicado: (2012)

A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study
por: Botson, John K., et al.
Publicado: (2022)

New-Onset Gout as an Independent Risk Factor for Returning to Dialysis After Kidney Transplantation
por: Li, Justin W., et al.
Publicado: (2020)

Construction and expression of recombinant uricase-expressing genetically engineered bacteria and its application in rat model of hyperuricemia
por: Cai, Liming, et al.
Publicado: (2020)

Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
por: Cockerham, Kimberly P., et al.
Publicado: (2021)

Correction to: Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
por: Cockerham, Kimberly P., et al.
Publicado: (2022)

Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
por: O’Hara, Steven P, et al.
Publicado: (2017)

Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks
por: Crisafulli, Salvatore, et al.
Publicado: (2020)

Dose–response relationship between protein intake and muscle mass increase: a systematic review and meta-analysis of randomized controlled trials
por: Tagawa, Ryoichi, et al.
Publicado: (2020)

Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development
por: Srinivasan, Meenakshi, et al.
Publicado: (2020)

Comparison of Two Corticosteroid Pre-Infusion Regimens for Pegloticase in the United States: A Retrospective Analysis in Community Rheumatology Practices
por: Majjhoo, Amar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ej03e2u5pnb24phpvfvl6hl01e